Correlation Between Veracyte and Allovir
Can any of the company-specific risk be diversified away by investing in both Veracyte and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Allovir, you can compare the effects of market volatilities on Veracyte and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Allovir.
Diversification Opportunities for Veracyte and Allovir
Excellent diversification
The 3 months correlation between Veracyte and Allovir is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Veracyte i.e., Veracyte and Allovir go up and down completely randomly.
Pair Corralation between Veracyte and Allovir
Given the investment horizon of 90 days Veracyte is expected to generate 0.54 times more return on investment than Allovir. However, Veracyte is 1.84 times less risky than Allovir. It trades about 0.04 of its potential returns per unit of risk. Allovir is currently generating about -0.04 per unit of risk. If you would invest 2,980 in Veracyte on September 3, 2024 and sell it today you would earn a total of 1,315 from holding Veracyte or generate 44.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Allovir
Performance |
| Timeline |
| Veracyte |
| Allovir |
Veracyte and Allovir Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Allovir
The main advantage of trading using opposite Veracyte and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Allovir vs. Anebulo Pharmaceuticals | Allovir vs. Mineralys Therapeutics, Common | Allovir vs. AN2 Therapeutics | Allovir vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |